Introduction
We are doctors looking after patients with blood disorders and scientists studying blood conditions in the lab. Our aim is to deliver the best expert and compassionate care for patients with blood diseases and patients who need blood cell transfusions. We want to reduce the burden of disease now and in the future, through our research, services, education, outreach and advocacy.
Our group includes international, scientific and clinical leaders. We draw on our combined expertise to carry out research and develop new services. Through our work we aim to:
- Improve the cost-effectiveness of cancer therapies and the outcomes of treatment – by developing new single cell approaches which tailor treatments to individuals. Find out more
- Improve the management of common and rare anaemias – by studying the role of iron and inflammation in anaemic patients, especially those who are elderly, and by developing a new national NHS service for patients with rare inherited red cell disorders. Find out more
- Improve the outcomes of blood cell and blood component transfusions – by using advanced e-tools and carrying out clinical trials to find out what approaches work best. Find out more
- Involve patients and carers in the key steps of our research projects. Find out more
Related websites
Oxford Centre for Haematology website: rdm.ox.ac.uk/och
RDM – HaemBio Biobank pages:
rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/och/haembio
NSSG website: nssg.oxford-haematology.org.uk
Introductory Talk by Haematology and Stem Cells Theme Lead Professor Paresh Vyas
Dr Susie Shapiro discusses research into thrombosis and COVID-19
In this webinar hosted by Thrombosis UK, BRC Haematology and Stem Cells theme researcher Dr Susie Shapiro speaks about her research on thrombosis in relation to COVID-19.
Follow the Oxford Centre for Haematology on Twitter
Congratulations @SJMorrison_ !!
🎉Join us in congratulating our Director, Sean Morrison (@SJMorrison_), who was elected to the @theNASciences today - one of the highest honors for American scientists.
Learn more about him and his award-winning research. ➡️https://t.co/oQmAxzY2J5
@TAMESTX @HHMINEWS @ISSCR
New @OxfordBRC funded collaboration between @NDCNOxford @ICNARC and @OxPrimaryCare to assess links between medications for chronic conditions and severity of COVID-19 #covid19 #QResearch
BRC funds new COVID-19 research projects
The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to three COVID-19 research projects in an attempt to improve treatment, underst...
www.ndcn.ox.ac.uk
Researchers from the @MRC_WIMM form part of the haematology team who have received @OxfordBRC funding to investigate biomarkers that predict adverse outcome in COVID-19 infection.
NIHR Oxford Biomedical Research Centre on Twitter
“We are funding 3 more #COVID19 studies Prof Andy Pollard & Dr Daniel O’Connor @OxfordVacGroup are using multi-omic techniques to ass...
twitter.com
The annual Excellent Supervision Awards, which this year go to @DrAJLewandowski and the @MRC_WIMM's Adam Mead. Many congratulations to the two Adams, and read more about what their students had to say about them: https://t.co/VC5X1p7VcA
Congratulations to Dr. John Dick on receiving the 2020 Pezcoller Foundation-@AACR International Award for Extraordinary Achievement in Cancer Research.
Read more here: https://t.co/rjorEAhNxI https://t.co/1vdNnpQQyH
Happy to see this published- the result of a wonderful collaboration with @adamdesmith. Thanks to @bloodwise_uk and #UKChildhoodLeukaemiaCellBank
Blood Advances on Twitter
“Stimulus Report: Germline variants in predisposition genes in children with Down syndrome and #ALL #leusm https://t.co/ZbuvWINqAJ”
twitter.com